Výsledky vyhledávání - "T E, Verstraelen"

The phospholamban (PLN) p.Arg14del risk model; Longitudinal validation and reevaluation of predictors regarding sudden cardiac death (SCD)

Autor: M Y C Van Der Heide, T E Verstraelen, F H M Van Lint, L P Bosman, R De Brouwer, V M Proost, T Germans, C Dickhoff, B A Schoonderwoerd, A C Houweling, J R Gimeno-Blanes, R A De Boer, M G P J Cox, P Van Tintelen, A A M Wilde

Publikováno v: Europace. 25

Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): PSIDER (ZOn-MW) PREDICT2 (Hartstichting) Background: The PLN p.Arg14del risk model is a mutation-specific risk model developed to predict individual mali

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::54e0bf92a954dbec5bfdba3d9f1637a4
https://doi.org/10.1093/europace/euad122.344

Zobrazit plný text záznamu

Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model

Autor: M Van Der Heide, T E Verstraelen, F H M Van Lint, L P Bosman, R De Brouwer, V M Proost, G S Abeln, B A Schoonderwoerd, A C Houweling, J R Gimeno-Blanes, F W Asselbergs, R A De Boer, M P Van Den Berg, J P Van Tintelen, A A M Wilde

Publikováno v: European Heart Journal. 43

Background/Introduction Recently, a variant-specific prediction model for PLN p.Arg14del variant carriers was developed to predict individual malignant ventricular arrhythmia (VA) risk to inform decision-making for primary prevention implantable card

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c639d59c940c19639952752d2b097fe6
https://doi.org/10.1093/eurheartj/ehac544.673

Zobrazit plný text záznamu

Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohort

Autor: M, van Barreveld, T E, Verstraelen, E, Buskens, P F H M, van Dessel, L V A, Boersma, P P H M, Delnoy, A E, Tuinenburg, D A M J, Theuns, P H, van der Voort, G P, Kimman, A H, Zwinderman, A A M, Wilde, M G W, Dijkgraaf

Publikováno v: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Implantation of an implantable cardioverter defibrillator (ICD) is standard care for primary prevention of sudden cardiac death. However, ICD-related complications are increasing as the population of ICD recipients grows.ICD-related complications in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1065b96676196dd6b56f9da5aa0b7df7
https://pubmed.ncbi.nlm.nih.gov/36434382

Zobrazit plný text záznamu

Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy : An updated meta-analysis and effect on Dutch clinical practice by the Task Force of the Dutch Society of Cardiology

Autor: D A, Theuns, T E, Verstraelen, A C J, van der Lingen, P P, Delnoy, C P, Allaart, L, van Erven, A H, Maass, K, Vernooy, A A M, Wilde, E, Boersma, J G, Meeder

Publikováno v: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Primary prophylactic implantable cardioverter-defibrillators (ICDs) in patients with non-ischaemic cardiomyopathy (NICMP) remains controversial. This study sought to assess the benefit of ICD therapy with or without cardiac resynchronisation therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ab61feee6277e9c4166b8da867d23abf
https://pubmed.ncbi.nlm.nih.gov/36066840

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání